Can-Fite Secures Japanese Patent Allowance for Namodenoson's Anti-Obesity Technology
· can-fite biopharma ltd.
Source Summary
The allowed Patent strengthens protection in one of the world's largest pharmaceutical markets and further supports Namodenoson's positioning in obesity and metabolic diseases
Advertisement